您的购物车当前为空
别名 Isoquinoline
IBR2 (Isoquinoline) is a potent and specific RAD51 inhibitor known for its ability to suppress RAD51-mediated DNA double-strand break repair. By interfering with RAD51 multimerization, accelerating proteasome-mediated RAD51 protein degradation, inhibiting cancer cell growth, and inducing apoptosis, IBR2 has proved to be an effective compound in these aspects.


为众多的药物研发团队赋能,
让新药发现更简单!
IBR2 (Isoquinoline) is a potent and specific RAD51 inhibitor known for its ability to suppress RAD51-mediated DNA double-strand break repair. By interfering with RAD51 multimerization, accelerating proteasome-mediated RAD51 protein degradation, inhibiting cancer cell growth, and inducing apoptosis, IBR2 has proved to be an effective compound in these aspects.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 239 | In stock | |
| 5 mg | ¥ 519 | In stock | |
| 10 mg | ¥ 892 | In stock | |
| 25 mg | ¥ 1,930 | In stock | |
| 50 mg | ¥ 2,930 | In stock | |
| 100 mg | ¥ 4,330 | In stock | |
| 200 mg | ¥ 6,130 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 459 | In stock |
IBR2 相关产品
| 产品描述 | IBR2 (Isoquinoline) is a potent and specific RAD51 inhibitor known for its ability to suppress RAD51-mediated DNA double-strand break repair. By interfering with RAD51 multimerization, accelerating proteasome-mediated RAD51 protein degradation, inhibiting cancer cell growth, and inducing apoptosis, IBR2 has proved to be an effective compound in these aspects. |
| 靶点活性 | RAD51:14.8 µM(triple-negative human breast cancer cell line MBA-MD-468) |
| 体外活性 | IBR2可抑制三阴性人乳腺癌细胞株MBA-MD-468的生长,其半抑制浓度(IC50)为14.8 μM。IBR2展现出对RAD51的显著抑制活性,治疗后的癌细胞中RAD51快速降解,其同源重组修复功能受损,进而导致细胞死亡。IBR2对大多数测试的癌症细胞株的IC50值范围在12-20 μM之间[1]。 |
| 别名 | Isoquinoline |
| 分子量 | 400.49 |
| 分子式 | C24H20N2O2S |
| CAS No. | 313526-24-8 |
| Smiles | O=S(=O)(Cc1ccccc1)N1C=Cc2ccccc2C1c1c[nH]c2ccccc12 |
| 密度 | 1.38 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 100 mg/mL (249.69 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (9.99 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容